Abstract:Background Graphene, a two-dimensional material composed of carbon atoms, has garnered significant attention for its potential application in biosensors due to its unique electrical properties. Despite its promising attributes, however, the non-reproducible nature of graphene biosensors has hindered their widespread commercialization. This issue arises from the difficulty in obtaining a clean graphene layer due to: photoresist such as PMMA residues that effect the performance of graphene; etching process which affect the physical and chemical properties of graphene; variation in the coating of bio-receptors on to graphene. All these issues affect reliable and accurate sensor performance. These challenges have made it difficult for graphene biosensors to reach their full potential as commercial products and have limited their widespread adoption. Hememics has developed a unique process for synthesizing and fabricating graphene-based biosensors. This represents a major breakthrough in the commercialization of graphene-based biosensors and will likely lead to widespread adoption of these devices in the medical and biotechnology industries. Methods HemChip™ contains multiple sensor areas that are coated with ultra-sensitive graphene. Using Hememics’ unique proprietary process, the graphene layer is functionalized with bioreceptors such as aptamers and stabilized with HemSol™ to allow room temperature storage. The relative difficulty of stabilizing aptamers on a hydrophobic graphene substrate has been overcome by using HemSol™ to secure its structure during dry storage. Each sensor on the biochip allows independent functionalization with a bioreceptor. These sensors coated with bioreceptors are freeze-dried and stored in a sealed pouch at room temperature until use. Results We have tested over 2000 samples using our modified process. The functionality of the graphene-based biosensor is evaluated by measuring the distribution of Dirac points. The results show that the distribution follows a Gaussian distribution with a median of 80 mV and a very narrow spread of approximately 35 mV. This indicates that the majority of the Dirac points are tightly clustered around the median value of 80 mV. Furthermore, one standard deviation of the Dirac points fall within the range of 50 mV to 120 mV. In contrast, the standard published process of producing graphene-based biosensor shows a much wider distribution of Dirac points, ranging from 250–1500 mV. Conclusion Hememics has developed a production process for making graphene-based biosensors with desiccated detection biology that deliver repeatable performance data. The results of the Dirac point distribution demonstrate the high precision and accuracy for the functionalized biosensors. This combined with the ability to mass produce the biosensor, make graphene-based biosensors an attractive molecular and immuno-based detection tool. Additionally, the results suggest that the Hememics process can be adapted to produce functional graphene-based biosensors for wide ranging bio detection applications.

A monocrystal graphene domain biosensor array with differential output for real-time monitoring of glucose and normal saline.

Development of glucose biosensors based on nanostructured graphene-conducting polyaniline composite.

Integrated biosensor platform based on graphene transistor arrays for real-time high-accuracy ion sensing

Monolayer Two‐dimensional Molecular Crystals for an Ultrasensitive OFET‐based Chemical Sensor

Wafer-scale graphene field-effect transistor biosensor arrays with monolithic CMOS readout

Ph and Non-Enzymatic Glucose Response at Ultra-Low Concentration Using Submicrochannel Heterogeneous Membrane

Dielectric‐Modulated Biosensing with Ultrahigh‐Frequency‐Operated Graphene Field‐Effect Transistors

pH monitoring in high ionic concentration environments: performance study of graphene-based sensors

Combination of cascade chemical reactions with graphene-DNA interaction to develop new strategy for biosensor fabrication.

An Ultrathin Flexible Affinity-Based Graphene Field-Effect Transistor For Glucose Monitoring

Oxide-on-graphene Field Effect Bio-Ready Sensors

Real-time reliable determination of binding kinetics of DNA hybridization using a multi-channel graphene biosensor

A-360 Reproducible Graphene Sensor with Desiccated Biology

Surface-tailored graphene channels

Ultrasensitive Biochemical Sensing Platform Enabled by Directly Grown Graphene on Insulator

Polyethylene Glycol Functionalized Silicon Nanowire Field-Effect Transistor Biosensor for Glucose Detection

An enzyme-free quartz crystal microbalance biosensor for sensitive glucose detection in biological fluids based on glucose/dextran displacement approach

High sensitivity glucose detection at extremely low concentrations using a MoS2-based field-effect transistor

On-chip Highly Sensitive Saliva Glucose Sensing Using Multilayer Films Composed of Single-Walled Carbon Nanotubes, Gold Nanoparticles, and Glucose Oxidase

Bimetal Thin Film, Semiconductors, and 2D Nanomaterials in SPR Biosensors: An Approach to Enhanced Urine Glucose Sensing

Ultrasensitive Field-Effect Biosensors Enabled by the Unique Electronic Properties of Graphene